It was proposed that co-treatment of MOLT-4 cells with TRAIL + kaempferol is a practical and striking approach to eliminate cancer resistance to TRAIL via intracellular anti-apoptotic protein inhibition, upregulation of DR4/5 and by suppression of the FGF-8 and VEGF-β expressions [144]. This evidence concerns the gene FGF8 and cancer.